These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11817317)

  • 61. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.
    Santos C; Pérez-Fontán M; Rodríguez-Carmona A; Calvo-Rodríguez M; López-Muñiz A; López-Calviño B; García-Falcón T
    Perit Dial Int; 2016; 36(1):43-51. PubMed ID: 25292406
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.
    Zimmerman SW; Ahrens E; Johnson CA; Craig W; Leggett J; O'Brien M; Oxton L; Roecker EB; Engeseth S
    Am J Kidney Dis; 1991 Aug; 18(2):225-31. PubMed ID: 1867179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does catheter immobilization reduce exit-site infections in CAPD patients?
    Turner K; Edgar D; Hair M; Uttley L; Sternland R; Hunt L; Gokal R
    Adv Perit Dial; 1992; 8():265-8. PubMed ID: 1361803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
    Herwaldt LA
    J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD.
    Lye WC; Leong SO; Lee EJ
    Kidney Int; 1993 Jun; 43(6):1357-62. PubMed ID: 8315950
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
    Pérez-Fontán M; Rosales M; Rodríguez-Carmona A; Moncalián J; Fernández-Rivera C; Cao M; Valdés F
    Adv Perit Dial; 1992; 8():242-5. PubMed ID: 1361797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
    Xu G; Tu W; Xu C
    Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peritonitis associated with exit site and tunnel infections.
    Gupta B; Bernardini J; Piraino B
    Am J Kidney Dis; 1996 Sep; 28(3):415-9. PubMed ID: 8804241
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Carrier-status for nasal staphylococci does not predict infections in CAPD patients.
    Lubrich-Birkner I; Schollmeyer P; Böhler J
    Adv Perit Dial; 1994; 10():154-7. PubMed ID: 7999816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME
    Adv Ther; 2007; 24(2):387-93. PubMed ID: 17565930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis.
    Grothe C; Taminato M; Belasco A; Sesso R; Barbosa D
    BMC Nephrol; 2016 Aug; 17(1):115. PubMed ID: 27527505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chlorhexidine for routine PD catheter exit-site care.
    Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
    Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients.
    Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):89-95. PubMed ID: 2200261
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
    Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peritoneal dialysis. Prevention and control of infection.
    Gokal R
    Drugs Aging; 2000 Oct; 17(4):269-82. PubMed ID: 11087005
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients.
    Piraino B; Bernardini J; Florio T; Fried L
    Perit Dial Int; 2003; 23(5):456-9. PubMed ID: 14604197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.
    Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA
    Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
    Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention of peritonitis in peritoneal dialysis.
    Segal JH; Messana JM
    Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.